Publications
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
APG777, anti-IL-13 monoclonal antibody, demonstrates extended half-life and sustained inhibition of Type 2 inflammatory biomarkers
Authors: Xiu Qin Lim, Erica Winter, Kristine Nograles, Sai Thankamony, Lukas Dillinger, Carl Dambkowski American College of Allergy, Asthma & Immunology’s (ACAAI) 2024 Annual Scientific Meeting, Boston, MA, USA, 24-28 October 2024.
APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13, demonstrates prolonged half-life and pSTAT6 inhibition in non-human primates
Authors: Eric Zhu, Jason Oh, Lukas Dillinger, and Hussam ShaheenSociety of Investigative Dermatology (SID) Annual Meeting, Dallas, TX, USA, 15–18 May, 2024
Prolonged half-life and sustained inhibition of key inflammatory biomarkers: a phase 1 study of APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13
Authors: Xiu Qin Lim, Erica Winter, Kristine Nograles, Sai Thankamony, Lukas Dillinger, Carl DambkowskiSociety of Investigative Dermatology (SID) Annual Meeting, Dallas, TX, USA, 15–18 May, 2024
APG777, anti-IL-13 monoclonal antibody, demonstrates extended half-life and sustained inhibition of Type 2 inflammatory biomarkers
Authors: Xiu Qin Lim, Erica Winter, Kristine Nograles, Sai Thankamony, Lukas Dillinger, Carl Dambkowski American College of Allergy, Asthma & Immunology’s (ACAAI) 2024 Annual Scientific Meeting, Boston, MA, USA, 24-28 October 2024.
APG777, a high-affinity humanized IgG1 monoclonal antibody targeting IL-13, demonstrates prolonged half-life and pSTAT6 inhibition in non-human primates
Authors: Eric Zhu, Jason Oh, Lukas Dillinger, and Hussam ShaheenSociety of Investigative Dermatology (SID) Annual Meeting, Dallas, TX, USA, 15–18 May, 2024